What is sarcopenia?
Level 5 - mechanism / opinion, no new human data
Narrative review without systematic methodology or primary human data synthesis
PubMed 7493218 · doi:10.1093/gerona/50a.special_issue.5
What was done
This is a narrative review defining sarcopenia and detailing its physiological consequences, particularly the impact of age-related skeletal muscle loss on muscle strength, physical disability, daily energy expenditure, basal metabolic rate, and metabolic health.
What was found
In sedentary adults, fat-free mass decreases by approximately 15% between the third and eighth decades of life, contributing directly to a lower basal metabolic rate. Muscle mass is identified as the primary determinant of age- and sex-related differences in strength, regardless of extremity location or action (flexion vs extension). Reduced strength is linked to walking limitations, increased disability, and elevated fall prevalence in institutionalized elderly individuals.
Why it matters
It outlines the early foundational framework defining sarcopenia as a key contributor to age-related functional decline, fall risk, and metabolic impairment.
Limits
The abstract describes a narrative overview rather than a systematic review or meta-analysis; no primary participant numbers, inclusion criteria, or statistical measures of uncertainty are reported.
Cited by
- context Human muscle performance peaks around the third decade of life, after which people lose approximately 10% of muscle strength and mass every 10 years, with loss accelerating beyond 10% per decade in their 60s.